The Indian Pharmaceutical Industry a highly organized sector is estimated to be worth US$ 10 bn, growing at an annual rate of 9%. In world rankings, the domestic industry stands fourth in terms of volume and 13th in value terms. It is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology.. It ranks very high, in terms of technology, quality and range of medicines manufactured.
The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. It has expanded drastically in the last two decades. This industry meets around 70% of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. There are about 250 large units and about 8000 Small Scale Units, which form the core of the pharmaceutical industry in India. These units produce the complete range of pharmaceutical formulations, indigenously.
Clusterkraft has been working for these pharmaceutical units for quality assurance, BDS availability, cluster development etc. Since it’s a highly growing as well as a highly vulnerable sector as well Clusterkraft’s experience and expertise comes in handy for sustainable growth and development in this sector. Our running projects in various parts of the country have helped the pharmaceutical industry deliver best results.
Clusterkraft facilitated development of software “Product costing application” for pharmaceutical formulations at Ahmedabad cluster under Project Vikas funded by Microsoft and steered by NMCC, Government of India.